Travis C Mickle - Net Worth and Insider Trading
Travis C Mickle Net Worth
The estimated net worth of Travis C Mickle is at least $772,983 dollars as of 2024-04-25. Travis C Mickle is the President & CEO of Zevra Therapeutics Inc and owns about 171,774 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $772,983. Details can be seen in Travis C Mickle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Travis C Mickle has not made any transactions after 2022-05-25 and currently still holds the listed stock(s).
Transaction Summary of Travis C Mickle
Travis C Mickle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Travis C Mickle owns 1 companies in total, including Zevra Therapeutics Inc (ZVRA) .
Click here to see the complete history of Travis C Mickle’s form 4 insider trades.
Insider Ownership Summary of Travis C Mickle
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2022-05-25 | director & 10 percent owner & President & CEO |
Travis C Mickle Latest Holdings Summary
Travis C Mickle currently owns a total of 1 stock. Travis C Mickle owns 171,774 shares of Zevra Therapeutics Inc (ZVRA) as of May 25, 2022, with a value of $772,983.
Latest Holdings of Travis C Mickle
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2022-05-25 | 171,774 | 4.50 | 772,983 |
Holding Weightings of Travis C Mickle
Travis C Mickle Form 4 Trading Tracker
According to the SEC Form 4 filings, Travis C Mickle has made a total of 7 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 13,000 shares on May 25, 2022, which cost Travis C Mickle around $56,940.
Insider Trading History of Travis C Mickle
- 1
Travis C Mickle Trading Performance
GuruFocus tracks the stock performance after each of Travis C Mickle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Travis C Mickle is -1.42%. GuruFocus also compares Travis C Mickle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Travis C Mickle within 3 months outperforms 4 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Travis C Mickle's insider trading performs compared to the benchmark.
Performance of Travis C Mickle
Average Return
16.35%
Outperforming Transactions
42%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.41 | -1.42 | 18.37 | 16.35 | -18.98 | -31.48 |
| Relative Return to S&P 500(%) | -0.61 | -4.35 | 15.1 | 8.25 | -29.69 | -40.79 |
Travis C Mickle Ownership Network
Ownership Network List of Travis C Mickle
Ownership Network Relation of Travis C Mickle
Travis C Mickle Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
Travis C Mickle is the director & 10 percent owner & President & CEO of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include director & President and CEO Neil F. Mcfarlane , VP Fin & Corp Controller R. Laduane Clifton , and CCO & EVP & Bus. Development Joshua Schafer .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, Travis C Mickle made no insider transaction in Zevra Therapeutics Inc (ZVRA). Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 6,100 shares made by R. Laduane Clifton , a net purchase of 3,500 shares made by Joshua Schafer , and a net purchase of 1,000 shares made by Watton Corey Michael .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 77,819 shares were bought by its insiders, resulting in a net purchase of 77,819 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
Travis C Mickle Mailing Address
Above is the net worth, insider trading, and ownership report for Travis C Mickle. You might contact Travis C Mickle via mailing address: 2656 Crosspark Road, Suite 100, Coralville Ia 52241.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
